3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole
C42H30N4 — CID 139147020
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole
3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole (PubChem CID 139147020) has the molecular formula C42H30N4 and a molecular weight of 590.73 g/mol. Its IUPAC name is 3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole.
Molecular Properties
| Compound Name | 3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole |
|---|---|
| PubChem CID | 139147020 |
| Molecular Formula | C42H30N4 |
| Molecular Weight | 590.73 g/mol |
| Exact Mass | 590.25 |
| IUPAC Name | 3-anthracen-9-yl-1-[[4-[(5-anthracen-9-ylpyrazol-1-yl)methyl]phenyl]methyl]pyrazole |
| SMILES | c1ccc2c(-c3ccn(Cc4ccc(Cn5nccc5-c5c6ccccc6cc6ccccc56)cc4)n3)c3ccccc3cc2c1 |
| InChI | InChI=1S/C42H30N4/c1-5-13-35-31(9-1)25-32-10-2-6-14-36(32)41(35)39-22-24-45(44-39)27-29-17-19-30(20-18-29)28-46-40(21-23-43-46)42-37-15-7-3-11-33(37)26-34-12-4-8-16-38(34)42/h1-26H,27-28H2 |
| InChIKey | PDSKBKMQIGTQCO-UHFFFAOYSA-N |
| XLogP | 10.12 |
| TPSA | 35.64 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 590.73 |
| LogP ≤ 5 | 10.12 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139147020 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.